According to Baiyunshan's announcement, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., a holding subsidiary of the company, recently received a “Proprietary Drug Registration Certificate” for injectable cefazoline sodium issued by the Macao Special Administrative Region Government Drug Administration. The drug has previously passed the national generic drug quality and efficacy consistency evaluation. After approval, relevant entities will be authorized to sell it in Macau, which will help expand overseas market business, and will have no significant impact on the company's current performance.

According to Baiyunshan's announcement, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd., a holding subsidiary of the company, recently received a “Proprietary Drug Registration Certificate” for injectable cefazoline sodium issued by the Macao Special Administrative Region Government Drug Administration. The drug has previously passed the national generic drug quality and efficacy consistency evaluation. After approval, relevant entities will be authorized to sell it in Macau, which will help expand overseas market business, and will have no significant impact on the company's current performance.